ArticleFrontiers in endocrinology2025
Deep exploration and precise identification of key risk factors for diabetic peripheral neuropathy using the random forest algorithm.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetic peripheral neuropathy (DPN) is a prevalent and highly disabling complication of diabetes mellitus, associated with markedly increased rates of disability and mortality. Timely intervention and effective management have been consistently shown to substantially reduce the risk of DPN onset and progression. Methods: This retrospective cohort study analyzed 1, 004 hospitalized patients with type 2 diabetes mellitus (T2DM) admitted to the endocrinology department of a hospital in Jiangsu Province, China. A risk prediction model for DPN was developed using the Random Forest (RF) algorithm, while logistic regression analysis was employed to identify the major risk factors. The overarching aim was to provide a reliable risk assessment tool for clinical application. Findings: Five principal factors were identified as significantly associated with DPN risk: age (OR = 1.257, 95% CI [1.188-1.367], p < 0.001), serum 25(OH)D3 levels (OR = 0.791, 95% CI [0.759-0.854], p < 0.001), duration of diabetes (OR = 1.431, 95% CI [1.285-1.617], p < 0.001), glycated hemoglobin (HbA1c) (OR = 1.236, 95% CI [1.197-1.391], p < 0.001), and glycated serum protein (GSP) (OR = 1.091, 95% CI [1.047-1.201], p = 0.017). A DPN risk prediction model incorporating these variables achieved an area under the receiver operating characteristic curve (AUC) of 0.829 (95% CI: 0.802-0.857), demonstrating excellent discriminatory performance. Interpretation: The Random Forest-based DPN risk prediction model successfully identified five critical risk factors, offering a solid theoretical foundation for personalized strategies in DPN prevention and management among patients with diabetes. This model exhibits high predictive utility in clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.